A Phase II, Double-Blind, Placebo-Controlled, Trial Of NS2359 For The Treatment of Cocaine Dependence
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2017
At a glance
- Drugs NS 2359 (Primary)
- Indications Cocaine abuse
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from not yet recruiting to recruiting.
- 16 Dec 2015 According to Saniona's media release, in June, Saniona has granted rights to Treatment Research Center (TRC), to perform this trial.
- 16 Dec 2015 According to Saniona's media release, company is planning to initiate this trial during the first of 2016.